Whole genome sequencing identifies putative associations between genomic polymorphisms and clinical response to the antiepileptic drug levetiracetam
Dimitris V. Vavoulis, Alistair T. Pagnamenta, Knight Sjl., Melissa M. Pentony, M Armstrong, Elizabeth Caruana Galizia, Simona Balestrini, Sanjay M. Sisodiya, Jenny C. Taylor
This study uses whole genome sequencing to identify genomic variants associated with clinical response to levetiracetam in patients with epilepsy, finding common and rare variants in genes related to synaptic function and neurotransmission.
medRxiv · Sep 27, 2019 · PreprintGenetic & Genomic Medicine